This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
7 Feb 2012

India's Pharmacovigilance Committee to Meet for PvPI Programme

The meeting will discuss some of the pressing matters that needs to be focused to make the PvPI more effective in future.

The first meeting of the National Coordinating Centre (NCC) for Pharmacovigilance Programme of India (PvPI) will be held on February 15 at Indian Council of Medial Research (ICMR) in Delhi. The meeting will discuss some of the pressing matters that needs to be focused to make the PvPI more effective in future.

 

Dr G N Singh, secretary and scientific director of Indian Pharmacopoeia Commission (IPC), nodal agency for the PvPI, informed that this meeting will be of high importance as the meeting is aimed at discussing future course of the PvPI programme of the country, so that it will enable safe and judicious use of medicines by effectively monitoring adverse drug reactions (ADR's) of the same on the Indian population.

 

The meeting will be chaired by Dr V M Katoch who is the secreta

Related News